Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelActive TiUltra RP 5.0x15mm: medical device reports filed with FDA

600 reports name it, 2020–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

600
device reports naming the brand
0% of all MAUDE reports · about 106 a year
136
reports, 12 months to August 2026
100 in the 12 months before
1.7%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 600 reports that name the brand "NobelActive TiUltra RP 5.0x15mm" (endosseous dental implant), received between November 2020 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

136 reports arrived in the 12 months to August 2026, up 36% from 100 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.3%) and malfunction (1.7%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (60.2%), osseointegration problem (12.3%) and loss of osseointegration (12%). The patient problems coded most often are failure of implant, pain and abscess. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01632Sep 2021: 2Oct 2021: 6Nov 2021: 4Dec 2021: 42022Jan 2022: 8Feb 2022: 10Mar 2022: 4Apr 2022: 4May 2022: 6Jun 2022: 4Jul 2022: 12Aug 2022: 2Sep 2022: 8Oct 2022: 10Nov 2022: 4Dec 2022: 62023Jan 2023: 4Feb 2023: 20Mar 2023: 16Apr 2023: 10May 2023: 20Jun 2023: 20Jul 2023: 10Aug 2023: 18Sep 2023: 4Oct 2023: 14Nov 2023: 14Dec 2023: 102024Jan 2024: 10Feb 2024: 12Mar 2024: 4Apr 2024: 8May 2024: 4Jun 2024: 2Jul 2024: 16Aug 2024: 16Sep 2024: 6Oct 2024: 8Nov 2024: 2Dec 2024: 122025Jan 2025: 8Feb 2025: 14Mar 2025: 10Apr 2025: 2May 2025: 0Jun 2025: 2Jul 2025: 28Aug 2025: 8Sep 2025: 12Oct 2025: 4Nov 2025: 16Dec 2025: 122026Jan 2026: 4Feb 2026: 14Mar 2026: 12Apr 2026: 32May 2026: 8Jun 2026: 6Jul 2026: 8Aug 2026: 8

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0801602020: 820202021: 4620212022: 7820222023: 16020232024: 10020242025: 11620252026: 922026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.3%590
Malfunction1.7%10
Other0%0
Not given0%0

Who filed the report

Manufacturer report49.8%299
Voluntary report0%0
User facility report0%0
Distributor report50.2%301
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate36160.2%62.8%
Osseointegration problem7412.3%7.7%
Loss of osseointegration7212%22.4%
Patient device interaction problem305%0.3%
Migrationthe device moved from where it was placed111.8%0.1%
Activation, positioning or separation problem61%0%
Insufficient device problem information61%0.2%
Difficult to insertthe device was hard to insert40.7%0.4%
Device markings/labelling problema problem with the device markings or label20.3%0%
Fracturea broken bone20.3%1.6%
Premature separation20.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant37662.7%
Painpain, site not specified325.3%
Abscessa collection of pus122%
Appropriate clinical signs, symptoms and conditions term/code not available122%
Numbnessnumbness101.7%
Bone fracture(s)81.3%
Implant pain61%
Foreign body in patientpart of a device left in the patient40.7%
Inflammationinflammation40.7%
Fistula20.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelActive TiUltra RP 5.0x15mmProduct code DZEAll MAUDE reports
Reports6003,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.3%99.2%36.2%
Classified as malfunction1.7%0.8%62.3%
Filed by the manufacturer49.8%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelActive TiUltra RP 5.0x15mm reports

How many FDA reports name NobelActive TiUltra RP 5.0x15mm?

600 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 136 in the latest 12 months.

What kinds of events are reported?

injury (98.3%) and malfunction (1.7%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (60.2%), osseointegration problem (12.3%), loss of osseointegration (12%), patient device interaction problem (5%) and migration (1.8%). These are FDA's device problem codes as entered on the report.

Who files these reports?

distributor reports (50.2%) and manufacturer reports (49.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelActive TiUltra RP 5.0x15mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.